Objectives

After participating in this educational activity, attendees should be able to:
1. Describe the roles of the members of the healthcare team in their respective responsibilities for quality care.

1. Understand the relationship and possible mechanisms of aromatase inhibitors (AI) induced bone moss.
2. Review current data on treatment interventions to prevent AI induced bone loss.
3. Discuss management guidelines for AI associated bone loss in postmenopausal women with hormone sensitive breast cancer.

Faculty

Faryal Mirza, MD

Associate Professor of Medicine

Director, Ambulatory Medicine Clerkship

University of Connecticut School of Medicine

Baystate Medical Center 

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.